Most Common Organism in Adult Spontaneous Bacterial Peritonitis
Escherichia coli (E. coli) is the most common organism causing spontaneous bacterial peritonitis (SBP) in adults with cirrhosis. 1
Microbiology of SBP
- SBP is typically monomicrobial and most commonly caused by gram-negative aerobic bacteria, with E. coli being the predominant pathogen (occurring in approximately 32-67% of culture-positive cases) 1, 2
- Other common causative organisms include:
Changing Epidemiology of SBP
Recent studies have shown a shift in the microbial spectrum of SBP with increasing prevalence of gram-positive organisms, particularly in healthcare settings 3, 4
In nosocomial (hospital-acquired) SBP, there is a higher prevalence of:
The epidemiology differs between community-acquired and nosocomial infections:
Antibiotic Resistance Patterns
- There is increasing resistance to quinolones among gram-negative bacteria in SBP, with approximately 30% of isolated gram-negative bacteria being resistant to quinolones 1
- In patients on norfloxacin prophylaxis, SBP is more likely to be caused by quinolone-resistant gram-negative bacteria or gram-positive cocci 1
- The rate of cephalosporin-resistant gram-negative bacteria remains relatively low in patients with SBP 1
Clinical Implications
- Third-generation cephalosporins remain the first-line empirical treatment for community-acquired SBP due to their effectiveness against E. coli and other common pathogens 1
- For patients who develop SBP while on quinolone prophylaxis, cefotaxime or amoxicillin/clavulanic acid are recommended 1
- In healthcare settings or for nosocomial SBP, broader coverage may be needed due to the higher prevalence of resistant organisms 1, 3
Common Pitfalls to Avoid
- Failing to perform diagnostic paracentesis in all cirrhotic patients with ascites admitted to the hospital, as SBP may be asymptomatic in up to one-third of cases 1
- Not considering the possibility of secondary bacterial peritonitis (due to intestinal perforation) when multiple organisms are isolated from ascitic fluid 1
- Using quinolones empirically in patients already on quinolone prophylaxis or in areas with high quinolone resistance 1
- Delaying antibiotic treatment while waiting for culture results, as prompt empiric therapy is essential for improving outcomes 1, 5